151 related articles for article (PubMed ID: 7589644)
1. The myometrium of postmenopausal women produces prolactin in response to human chorionic gonadotropin and alpha-subunit in vitro.
Stewart EA; Jain P; Penglase MD; Friedman AJ; Nowak RA
Fertil Steril; 1995 Nov; 64(5):972-6. PubMed ID: 7589644
[TBL] [Abstract][Full Text] [Related]
2. Decreased prolactin secretion by explant cultures of fibroids from women treated with a gonadotropin-releasing hormone agonist.
Rein MS; Friedman AJ; Heffner LJ
J Clin Endocrinol Metab; 1990 Jun; 70(6):1554-8. PubMed ID: 2112150
[TBL] [Abstract][Full Text] [Related]
3. Leuprolide acetate-treated leiomyomas retain their relative overexpression of collagen type I and collagen type III messenger ribonucleic acid.
Stewart EA; Rhoades AR; Nowak RA
J Soc Gynecol Investig; 1998; 5(1):44-7. PubMed ID: 9501298
[TBL] [Abstract][Full Text] [Related]
4. Glycoprotein hormones and their common alpha-subunit stimulate prolactin production by explant cultures of human leiomyoma and myometrium.
Stewart EA; Rein MS; Friedman AJ; Zuchowski L; Nowak RA
Am J Obstet Gynecol; 1994 Feb; 170(2):677-83. PubMed ID: 7509571
[TBL] [Abstract][Full Text] [Related]
5. Onapristone suppresses prolactin production in explant cultures of leiomyoma.
Austin DJ; Nowak RA; Stewart EA
Gynecol Obstet Invest; 1999; 47(4):268-71. PubMed ID: 10352391
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
[TBL] [Abstract][Full Text] [Related]
7. RU486 suppresses prolactin production in explant cultures of leiomyoma and myometrium.
Stewart EA; Austin DJ; Jain P; Penglase MD; Nowak RA
Fertil Steril; 1996 Jun; 65(6):1119-24. PubMed ID: 8641483
[TBL] [Abstract][Full Text] [Related]
8. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
9. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
Malik M; Britten J; Cox J; Patel A; Catherino WH
Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma.
Senturk LM; Sozen I; Gutierrez L; Arici A
Am J Obstet Gynecol; 2001 Mar; 184(4):559-66. PubMed ID: 11262453
[TBL] [Abstract][Full Text] [Related]
11. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
Rein MS; Friedman AJ; Stuart JM; MacLaughlin DT
Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
Chegini N; Rong H; Dou Q; Kipersztok S; Williams RS
J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate.
Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Inoue M
J Clin Endocrinol Metab; 2001 Nov; 86(11):5405-11. PubMed ID: 11701714
[TBL] [Abstract][Full Text] [Related]
14. Production of prolactin by smooth muscle cells cultured from human uterine fibroid tumors.
Nowak RA; Rein MS; Heffner LJ; Friedman AJ; Tashjian AH
J Clin Endocrinol Metab; 1993 May; 76(5):1308-13. PubMed ID: 8496322
[TBL] [Abstract][Full Text] [Related]
15. Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions.
Englund K; Lindblom B; Carlström K; Gustavsson I; Sjöblom P; Blanck A
Mol Hum Reprod; 2000 Oct; 6(10):915-20. PubMed ID: 11006320
[TBL] [Abstract][Full Text] [Related]
16. Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
De Falco M; Staibano S; D'Armiento FP; Mascolo M; Salvatore G; Busiello A; Carbone IF; Pollio F; Di Lieto A
J Soc Gynecol Investig; 2006 May; 13(4):297-303. PubMed ID: 16697947
[TBL] [Abstract][Full Text] [Related]
17. Bone metabolism in postmenopausal women who were treated with a gonadotropin-releasing hormone agonist and tibolone.
Palomba S; Morelli M; Di Carlo C; Noia R; Pellicano M; Zullo F
Fertil Steril; 2002 Jul; 78(1):63-8. PubMed ID: 12095492
[TBL] [Abstract][Full Text] [Related]
18. The secretion of human chorionic gonadotropin as well as the alpha- and beta messenger ribonucleic acid levels are stimulated by exogenous gonadoliberin pulses applied to first trimester placenta in a superfusion culture system.
Merz WE; Erlewein C; Licht P; Harbarth P
J Clin Endocrinol Metab; 1991 Jul; 73(1):84-92. PubMed ID: 1710625
[TBL] [Abstract][Full Text] [Related]
19. Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas.
Palomba S; Orio F; Russo T; Falbo A; Cascella T; Doldo P; Nappi C; Lombardi G; Mastrantonio P; Zullo F
Hum Reprod; 2004 Jun; 19(6):1308-14. PubMed ID: 15117890
[TBL] [Abstract][Full Text] [Related]
20. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
Wu X; Blanck A; Olovsson M; Möller B; Lindblom B
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):497-504. PubMed ID: 11380284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
